Table 3.
Overview of the combined gene and cell therapy based treatment strategies for inflammatory bowel diseases as discussed in this review
Applied strategy | Viral vector used | Reference for viral vector used | Status of development | Reference for status of development | |
Combined gene and cell therapy | Ex vivo generated Treg/Tr1 | Retrovirus | [113,115] | Preclinical | [113,115] |
T cell receptor transgenic Treg | Retrovirus | [116] | Preclinical | [116] |
The status of development refers to research which has already been performed. Treg: CD4+CD25highFOXP3+ regulatory T cell; Tr1: Type 1 regulatory T cell.